Brevan Howard Capital Management LP Care Dx, Inc. Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q3 2024
A detailed history of Brevan Howard Capital Management LP transactions in Care Dx, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 6,665 shares of CDNA stock, worth $137,365. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,665
Previous 36,588
81.78%
Holding current value
$137,365
Previous $568,000
63.38%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding CDNA
# of Institutions
218Shares Held
51.1MCall Options Held
97.3KPut Options Held
43.3K-
Black Rock Inc. New York, NY5.29MShares$109 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$93.5 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.15MShares$64.8 Million1.65% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.99MShares$61.6 Million0.89% of portfolio
-
State Street Corp Boston, MA2.04MShares$42 Million0.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.1B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...